These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14510935)

  • 21. The significance of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Goldman JM
    Biol Blood Marrow Transplant; 2013 May; 19(5):679-80. PubMed ID: 23467125
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation.
    Guardiola P; Kuentz M; Garban F; Blaise D; Reiffers J; Attal M; Buzyn A; Lioure B; Bordigoni P; Fegueux N; Tanguy ML; Vernant JP; Gluckman E; Socié G
    Br J Haematol; 2000 Oct; 111(1):292-302. PubMed ID: 11091216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factor.
    Pocock CF; Lucas GF; Giles C; Vassiliou G; Cwynarski K; Rezvani K; Apperley JF; Goldman JM
    Br J Haematol; 2001 May; 113(2):483-5. PubMed ID: 11380420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
    Song CY; Li YH; Guo KY; Wu BY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):494, 497. PubMed ID: 12754143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Arpinati M; Tolomelli G; Bochicchio MT; Castagnetti F; Amabile M; Bandini G; Bonifazi F; Stanzani M; Rosti G; Martinelli G; Baccarani M
    Biol Blood Marrow Transplant; 2013 May; 19(5):735-40. PubMed ID: 23333776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenteric inflammatory veno-occlusive disease (MIVOD) after allogeneic peripheral blood stem cell transplantation (PBSCT).
    Pérez-Corral AM; Serrano D; Menarguez-Palanca J; Carrión R; Barreiro I; Gómez-Pineda A; Buño I; Balsalobre P; Diez-Martín JL
    Bone Marrow Transplant; 2008 Feb; 41(3):311-3. PubMed ID: 18026155
    [No Abstract]   [Full Text] [Related]  

  • 29. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation.
    Baron F; Dresse MF; Beguin Y
    N Engl J Med; 2003 Aug; 349(9):913-4. PubMed ID: 12944584
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.
    Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Frassoni F; Sessarego M; Fugazza G; Di Stefano F; Pitto A; Bacigalupo A
    Br J Haematol; 2000 Jun; 109(4):716-21. PubMed ID: 10929020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
    Khoury H; Adkins D; Brown R; Vij R; Westervelt P; Trinkaus K; Goodnough LT; DiPersio JF
    Bone Marrow Transplant; 2000 Jun; 25(11):1197-201. PubMed ID: 10849533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Nadal E; Garin M; Kaeda J; Apperley J; Lechler R; Dazzi F
    Leukemia; 2007 Mar; 21(3):472-9. PubMed ID: 17215853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic eosinophilic colitis in a patient with previous allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Shindano A; Geubel A; Fervaille C; Azzouzi K
    Acta Gastroenterol Belg; 2009; 72(2):267-8. PubMed ID: 19637788
    [No Abstract]   [Full Text] [Related]  

  • 36.
    Lee SE; Choi SY; Kim SH; Song HY; Yoo HL; Lee MY; Kang KH; Hwang HJ; Jang EJ; Kim DW
    Korean J Intern Med; 2017 Jan; 32(1):125-136. PubMed ID: 27334764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purine nucleoside analogues in the treatment of myleoid leukemias.
    Robak T
    Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.
    Kreuzer KA; Klühs C; Baskaynak G; Movassaghi K; Dörken B; le Coutre P
    Br J Haematol; 2004 Jan; 124(2):195-9. PubMed ID: 14687030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation.
    Bee PC; Gan GG; Sangkar VJ; Haris AR
    Med J Malaysia; 2008 Mar; 63(1):71-2. PubMed ID: 18935742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: a single-centre experience.
    Olavarria E; Kanfer E; Szydlo R; O'Brien S; Craddock C; Apperley J; Goldman J
    Br J Haematol; 2000 Mar; 108(4):769-77. PubMed ID: 10792282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.